BCYC Earnings & Financial Statements
Bicycle Therapeutics plc
$3.89
+$0.08(+2.10%)
45
Overall
60
Value
30
Tech
47
Quality
Market Cap
$272.27M
Volume
300.62K
52W Range
$3.33 - $9.08
Target Price
$9.86
BCYC earnings and financial statements: Bicycle Therapeutics plc's income statement, balance sheet and cash flow statement, annual and quarterly.
BCYC Annual Financial Statements
| Fiscal year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | $35.27M | $26.98M | $14.46M | $11.70M | $10.39M |
| Operating income | -$209.87M | -$189.95M | -$116.65M | -$65.62M | -$51.96M |
| EBITDA | -$164.89M | -$172.65M | -$110.90M | -$64.09M | -$50.00M |
| Net income | -$169.00M | -$180.70M | -$112.72M | -$66.82M | -$51.00M |
| EPS (diluted) | $-2.90 | $-5.08 | $-3.80 | $-2.67 | $-2.66 |
| Fiscal year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total assets | $956.87M | $595.34M | $410.61M | $479.79M | $161.15M |
| Total liabilities | $163.81M | $224.41M | $139.83M | $133.54M | $65.69M |
| Shareholders’ equity | $793.06M | $370.93M | $270.78M | $346.25M | $95.46M |
| Cash and equivalents | $879.50M | $526.42M | $339.15M | $438.68M | $135.99M |
| Long-term debt | $3.99M | $40.08M | $41.20M | $41.95M | $14.93M |
| Fiscal year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating cash flow | -$164.72M | -$60.63M | -$86.11M | -$14.79M | -$17.79M |
| Capital expenditure | -$1.24M | -$2.93M | -$18.99M | -$2.03M | -$1.20M |
| Free cash flow | -$165.96M | -$63.56M | -$105.10M | -$16.82M | -$18.99M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCYC | $3.89 | +2.1% | 300.62K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bicycle Therapeutics plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW